For: | Gougelet A. Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma. World J Hepatol 2018; 10(11): 785-789 [PMID: 30533178 DOI: 10.4254/wjh.v10.i11.785] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i11/785.htm |
Number | Citing Articles |
1 |
Angélique Gougelet, Christèle Desbois-Mouthon. Non-coding RNAs open a new chapter in liver cancer treatment. Clinics and Research in Hepatology and Gastroenterology 2019; 43(6): 630 doi: 10.1016/j.clinre.2019.07.005
|
2 |
Tanghua Li, Jiapeng Jiao, Haoteng Ke, Wenshan Ouyang, Luobin Wang, Jin Pan, Xin Li. Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1200201
|
3 |
Xin Li, Chuanyun Li, Liping Zhang, Min Wu, Ke Cao, Feifei Jiang, Dexi Chen, Ning Li, Weihua Li. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-019-1085-0
|
4 |
Xiaoyan Shi, Xianmei Xie, Ying Sun, Hai He, Hanwen Huang, Yarong Liu, Hongfei Wu, Min Dai. Paeonol inhibits NLRP3 mediated inflammation in rat endothelial cells by elevating hyperlipidemic rats plasma exosomal miRNA-223. European Journal of Pharmacology 2020; 885: 173473 doi: 10.1016/j.ejphar.2020.173473
|
5 |
Dongdong Xue, Jingzhao Han, Yifan Liu, Hongfang Tuo, Yanhui Peng. Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review). Cancer Biology & Therapy 2021; 22(4): 279 doi: 10.1080/15384047.2021.1898728
|
6 |
Qi Liu, Shiying Li, Amandine Dupuy, Hoa le Mai, Nicolas Sailliet, Cédric Logé, J.-Michel H. Robert, Sophie Brouard. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives. International Journal of Molecular Sciences 2021; 22(15): 7763 doi: 10.3390/ijms22157763
|
7 |
Si-nan Sun, Shuang Hu, Yu-ping Shang, Liang-yun Li, Hong Zhou, Jia-si Chen, Jun-fa Yang, Jun Li, Qiang Huang, Chuan-pu Shen, Tao Xu. Relevance function of microRNA-708 in the pathogenesis of cancer. Cellular Signalling 2019; 63: 109390 doi: 10.1016/j.cellsig.2019.109390
|
8 |
Julie Sanceau, Angélique Gougelet. Clinical Applications of Non-Coding RNAs in Cancer. 2022; : 343 doi: 10.1016/B978-0-12-824550-7.00007-2
|
9 |
Tuoyu Ju, Fan Yang, Ying Wang, Zhengxun Song, Hongmei Xu, Yujuan Chen, Zuobin Wang. Effect of SMMC-7721-derived exosomes on hepatocytes studied by AFM. 2021 IEEE International Conference on Manipulation, Manufacturing and Measurement on the Nanoscale (3M-NANO) 2021; : 148 doi: 10.1109/3M-NANO49087.2021.9599805
|
10 |
Jun‐Cheng Guo, Yi‐Jun Yang, Jian‐Quan Zhang, Min Guo, Li Xiang, Shu‐Feng Yu, Huang Ping, Liu Zhuo. microRNA‐448 inhibits stemness maintenance and self‐renewal of hepatocellular carcinoma stem cells through the MAGEA6‐mediated AMPK signaling pathway. Journal of Cellular Physiology 2019; 234(12): 23461 doi: 10.1002/jcp.28915
|
11 |
Nikita Thapa, Yong Chwae, Kwang Yoo, Tae-Bin Won, Daewook Kang, Daae Choi, Jaeyoung Kim. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review). International Journal of Molecular Medicine 2022; 51(1) doi: 10.3892/ijmm.2022.5206
|